Company record · VSBC · Services-Commercial Physical & Biological Research
VitaSpring Biomedical Co. Ltd.
VitaSpring Biomedical Co. Ltd.'s chief financial officer on the record is Jing-Zhou Chen, effective September 7, 2026, per the filing record.
The record holds 1 verified CFO change for VitaSpring Biomedical Co. Ltd. from Form 8-K filings, filed September 10, 2026 and the CFO signature on its 10-K filed June 17, 2026.
The CFO seat
Computed from the records below: a move filed on or after the 10-K replaces the 10-K's signature.
| Status | Filled |
|---|---|
| Officer | Jing-Zhou Chen |
| Title as printed | Chief Executive Officer, President, Chief Financial Officer, and Secretary |
| Basis | Latest move: transition, 8-K filed September 10, 2026 |
Seat timeline
2Every verified record for this seat, newest first, dated as the filing states it.
2026-09-10Transition
VitaSpring Biomedical Co. Ltd. CFO transition: Jing-Zhou Chen to succeed Ssu-Chuan Laieffective September 7, 2026 · 8-K filed September 10, 2026 · sec.gov, Item 5.02
2026-06-1710-K signature
Ssu-Chuan Lai signed the annual report as Director, President and Chief Executive Officer (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)
10-K filed June 17, 2026 · sec.gov
“/s/ Ssu-Chuan Lai Ssu-Chuan Lai Director, President and Chief Executive Officer (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)”
Company
| Ticker | VSBC |
|---|---|
| SEC CIK | 0001697884 |
| Industry (SIC) | Services-Commercial Physical & Biological Research (8731) |
| Roster note | No DEF 14A in the recent filings to cross-check. An 8-K with Item 5.02 was filed on 2026-09-10, after this 10-K; any CFO change it reports is tracked on the moves record. |
Same industry on the record
4Other companies the roster files under SIC “Services-Commercial Physical & Biological Research”.
This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.